Kathleen Tierney-Oconnor
Pediatrics · Great Neck, NYNPI 1295874741
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $688, 2.4 times the $288 reported in 2019. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$487
- ARS Pharmaceuticals Operations, Inc.$259
- Kaleo, Inc.$257
- Cranial Technologies, Inc$172
- Sanofi Pasteur Inc.$167
- Merck$154
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,584100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $487 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $259 |
| Kaleo, Inc. | 13 | $257 |
| Cranial Technologies, Inc | 11 | $172 |
| Sanofi Pasteur Inc. | 8 | $167 |
| Merck | 7 | $154 |
| Kowa Pharmaceuticals America, Inc. | 7 | $152 |
| Aytu Biopharma, Inc. | 8 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $139 |
| Corium, LLC | 7 | $134 |
| GSK | 5 | $131 |
| Vertical Pharmaceuticals, LLC | 5 | $78 |
| Phadia US Inc. | 5 | $77 |
| Seqirus USA Inc | 3 | $64 |
| Sobi, Inc | 3 | $57 |
| Shire North American Group Inc | 2 | $37 |
| AstraZeneca | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEFFY$125
How this compares
$2,584 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 12 | $117 |
| Mometasone Furoate | 11 | $68 |
| Mupirocin | 12 | $21 |
| Chlorhexidine Gluconate | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Great Neck
- Joan Decelie-GermanaGreat Neck$12K
- Philip OzuahBronx$1M
- Michael PichicheroRochester$168K
- Patrick SchnellBrooklyn$164K
- Warren SeigelBrooklyn$162K
- Rachael PhelpsRochester$156K
- Sarita GeorgeMineola$90K
- Kathryn FitzgeraldNew York$80K
- Rudolph LeibelNew York$67K
- Shakeel ModakNew York$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.